Gotowa bibliografia na temat „T cells”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „T cells”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "T cells"
F. Abdel Hamid, Mahmoud, Safaa M. Morsy, Mostafa Abou El Ela, Rehab A. Hegazy, Marwa M. Fawzy, Laila A. Rashed, Ahmed M. Omar, Eman R. Abdel Fattah i Doaa M. Hany. "T helper-17 cells and T regulatory cells in vitiligo". International Journal of Academic Research 5, nr 6 (10.12.2013): 273–78. http://dx.doi.org/10.7813/2075-4124.2013/5-6/a.34.
Pełny tekst źródłaSingh, Yuvraj. "Chimeric Antigen Receptors T Cells (CAR T) Therapy". International Journal of Science and Research (IJSR) 13, nr 5 (5.05.2024): 1563–66. http://dx.doi.org/10.21275/sr24523173932.
Pełny tekst źródłaY, Elshimali. "Chimeric Antigen Receptor T-Cell Therapy (Car T-Cells) in Solid Tumors, Resistance and Success". Bioequivalence & Bioavailability International Journal 6, nr 1 (2022): 1–6. http://dx.doi.org/10.23880/beba-16000163.
Pełny tekst źródłaCPK, Cheung. "T Cells, Endothelial Cell, Metabolism; A Therapeutic Target in Chronic Inflammation". Open Access Journal of Microbiology & Biotechnology 5, nr 2 (2020): 1–6. http://dx.doi.org/10.23880/oajmb-16000163.
Pełny tekst źródłaMeuer, Stefan C. "T cells". Immunology Today 12, nr 1 (styczeń 1991): 49. http://dx.doi.org/10.1016/0167-5699(91)90117-c.
Pełny tekst źródłaStauss, Hans J. "Engineered T cells can fight malignant T cells". Blood 126, nr 8 (20.08.2015): 927–28. http://dx.doi.org/10.1182/blood-2015-07-652057.
Pełny tekst źródłaScott, David W. "T regulatory cells turn on T regulatory cells". Blood 114, nr 19 (5.11.2009): 3975–76. http://dx.doi.org/10.1182/blood-2009-09-241406.
Pełny tekst źródłaZahran F, Zahran F., Al-haggar M. Al-haggar M i Derbala S. A. Derbala S.A. "Regulatory T Cells in Pediatric Lupus Nephritis". Indian Journal of Applied Research 3, nr 10 (1.10.2011): 1–3. http://dx.doi.org/10.15373/2249555x/oct2013/91.
Pełny tekst źródłaNg, Y. H., M. H. Oberbarnscheidt, H. C. K. Chandramoorthy, R. Hoffman i G. Chalasani. "B Cells Help Alloreactive T Cells Differentiate Into Memory T Cells". American Journal of Transplantation 10, nr 9 (27.08.2010): 1970–80. http://dx.doi.org/10.1111/j.1600-6143.2010.03223.x.
Pełny tekst źródłaSuzuki, Haruhiko, Zhe Shi, Yusuke Okuno i Ken-ichi Isobe. "Are CD8+CD122+ cells regulatory T cells or memory T cells?" Human Immunology 69, nr 11 (listopad 2008): 751–54. http://dx.doi.org/10.1016/j.humimm.2008.08.285.
Pełny tekst źródłaRozprawy doktorskie na temat "T cells"
Carson, Bryan David. "Impaired T cell receptor signaling in regulatory T cells /". Thesis, Connect to this title online; UW restricted, 2006. http://hdl.handle.net/1773/8337.
Pełny tekst źródłaLloyd, Angharad. "Gene editing in T-cells and T-cell targets". Thesis, Cardiff University, 2016. http://orca.cf.ac.uk/98512/.
Pełny tekst źródłaStefkova, Martina. "Regulatory T cells control the CD4 T cell repertoire". Doctoral thesis, Universite Libre de Bruxelles, 2016. https://dipot.ulb.ac.be/dspace/bitstream/2013/233151/3/Table.pdf.
Pełny tekst źródłaRecent studies conducted in mice and humans have suggested a role for the TCR repertoire diversity in immune protection against pathogens displaying high antigenic variability. To study the CD4 T cell repertoire, we used a mouse model in which T cells transgenically express the TCRβ chain of a TCR specific to a MHCII-restricted peptide, env122-141. Upon immunization with peptide-pulsed dendritic cells, antigen-specific Vα2+ CD4+ T cells rapidly expand and display a restricted TCRα repertoire. In particular, analysis of receptor diversity by high-throughput TCR sequencing in immunized mice suggests the emergence of a broader CDR3 Vα2 repertoire in Treg-depleted mice. These results suggest that Tregs may play a role in the restriction of the CD4 T cell repertoire during an immune response, raising therefore the possibility that in addition to controlling the magnitude of an immune response, regulatory cells may also control the diversity of TCRs in response to antigen stimulation.
Doctorat en Sciences
info:eu-repo/semantics/nonPublished
Butcher, Sarah A. "T cell receptor genes of influenza A haemagglutinin specific T cells". Thesis, University College London (University of London), 1992. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.315271.
Pełny tekst źródłaCrawford, A. "How B cells influence T cell responses". Thesis, University of Edinburgh, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.645118.
Pełny tekst źródłaSarris, Milka. "Dynamics of helper T cell and regulatory T cell interactions with dendritic cells". Thesis, University of Cambridge, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.611896.
Pełny tekst źródłaSmith, Trevor Robert Frank. "Modulation of CD4+ T cell responses by CD4+CD25+ regulatory T cells and modified T cell epitopes". Thesis, Imperial College London, 2004. http://hdl.handle.net/10044/1/11317.
Pełny tekst źródłaMurray, Nicholas. "Costimulation of T cells and its role in T cell recognition of malignant colorectal cells in vitro". Thesis, University of Oxford, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.301247.
Pełny tekst źródłaLi, Ming 1957. "Generation of CD8+ T cell immunity with help from CD4+ T cells". Monash University, Dept. of Pathology and Immunology, 2002. http://arrow.monash.edu.au/hdl/1959.1/8476.
Pełny tekst źródłaSoper, David Michael. "Interleukin-2 receptor and T cell receptor signaling in regulatory T cells /". Thesis, Connect to this title online; UW restricted, 2007. http://hdl.handle.net/1773/8344.
Pełny tekst źródłaKsiążki na temat "T cells"
Marc, Feldmann, Lamb Jonathan R i Owen M. J, red. T cells. New York: Wiley, 1989.
Znajdź pełny tekst źródłaAnnunziato, Francesco, Laura Maggi i Alessio Mazzoni, red. T-Helper Cells. New York, NY: Springer US, 2021. http://dx.doi.org/10.1007/978-1-0716-1311-5.
Pełny tekst źródłaGigante, Margherita, i Elena Ranieri, red. Cytotoxic T-Cells. New York, NY: Springer US, 2021. http://dx.doi.org/10.1007/978-1-0716-1507-2.
Pełny tekst źródłaOno, Masahiro, red. Regulatory T-Cells. New York, NY: Springer US, 2023. http://dx.doi.org/10.1007/978-1-0716-2647-4.
Pełny tekst źródłaZanetti, Maurizio, i Stephen P. Schoenberger, red. Memory T Cells. New York, NY: Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-6451-9.
Pełny tekst źródłaRanieri, Elena, red. Cytotoxic T-Cells. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-1158-5.
Pełny tekst źródłaWaisman, Ari, i Burkhard Becher, red. T-Helper Cells. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-1212-4.
Pełny tekst źródłaKassiotis, George, i Adrian Liston, red. Regulatory T Cells. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-61737-979-6.
Pełny tekst źródłaZanetti, M. Memory T cells. New York: Springer Science+Business Media, 2010.
Znajdź pełny tekst źródłaGraca, Luis, red. T-Follicular Helper Cells. New York, NY: Springer US, 2022. http://dx.doi.org/10.1007/978-1-0716-1736-6.
Pełny tekst źródłaCzęści książek na temat "T cells"
Srinivasan, Ramachandran. "T Cells". W Encyclopedia of Systems Biology, 2119. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-9863-7_959.
Pełny tekst źródłaNomura, Takashi, i Aya Shinohara. "T Cells". W Immunology of the Skin, 57–94. Tokyo: Springer Japan, 2016. http://dx.doi.org/10.1007/978-4-431-55855-2_5.
Pełny tekst źródłaArampatzis, Adamantios, Lida Mademli, Thomas Reilly, Mike I. Lambert, Laurent Bosquet, Jean-Paul Richalet, Thierry Busso i in. "T Cells". W Encyclopedia of Exercise Medicine in Health and Disease, 843. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-540-29807-6_3106.
Pełny tekst źródłaSakaguchi, Shimon. "Regulatory T Cells: History and Perspective". W Regulatory T Cells, 3–17. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-61737-979-6_1.
Pełny tekst źródłaLahl, Katharina, i Tim Sparwasser. "In Vivo Depletion of FoxP3+ Tregs Using the DEREG Mouse Model". W Regulatory T Cells, 157–72. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-61737-979-6_10.
Pełny tekst źródłaDaniel, Carolin, Hidde Ploegh i Harald von Boehmer. "Antigen-Specific Induction of Regulatory T Cells In Vivo and In Vitro". W Regulatory T Cells, 173–85. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-61737-979-6_11.
Pełny tekst źródłaNouzé, Clémence, Lise Pasquet i Joost P. M. van Meerwijk. "In Vitro Expansion of Alloantigen-Specific Regulatory T Cells and Their Use in Prevention of Allograft Rejection". W Regulatory T Cells, 187–96. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-61737-979-6_12.
Pełny tekst źródład’Hennezel, Eva, i Ciriaco A. Piccirillo. "Analysis of Human FOXP3+ Treg Cells Phenotype and Function". W Regulatory T Cells, 199–218. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-61737-979-6_13.
Pełny tekst źródłaHobeika, Amy C., Michael A. Morse, Takuya Osada, Sharon Peplinski, H. Kim Lyerly i Timothy M. Clay. "Depletion of Human Regulatory T Cells". W Regulatory T Cells, 219–31. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-61737-979-6_14.
Pełny tekst źródłaSchneider, Anya, i Jane H. Buckner. "Assessment of Suppressive Capacity by Human Regulatory T Cells Using a Reproducible, Bi-Directional CFSE-Based In Vitro Assay". W Regulatory T Cells, 233–41. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-61737-979-6_15.
Pełny tekst źródłaStreszczenia konferencji na temat "T cells"
Mamonkin, Maksim. "Abstract IA17: CAR T cells for T-cell lymphoma". W Abstracts: AACR Virtual Meeting: Advances in Malignant Lymphoma; August 17-19, 2020. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/2643-3249.lymphoma20-ia17.
Pełny tekst źródłaAhmed, M. N., A. Chester, A. McCormack, K. Ayyasola, N. Zaghloul, E. Miller i M. Yacoub. "CD4+ ChAT+ T Cells (ChAT T Cells) as a New Vasodilator". W American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a2675.
Pełny tekst źródłaCorreia, Eduardo, Clara Andrade, Leonardo Silva, Brenno Sessa, Luiza Abdo, Karina Hajdu, Emmanuel Aragão i Martín Bonamino. "Generation of 19bbz CAR-T cells in tcr knockout T-cells". W International Symposium on Immunobiologicals. Instituto de Tecnologia em Imunobiológicos, 2023. http://dx.doi.org/10.35259/isi.2023_58059.
Pełny tekst źródłaRabin, Moriah, Erin Cole, Scott Garforth, Jian Hua Zheng, Steven Almo i Harris Goldstein. "295 Novel T-cell immunotherapeutics enable the selective generation of more potently cytotoxic CD19 chimeric antigen receptor T-cells (CAR-T cells) from CMV-specific cytotoxic T-cells". W SITC 38th Annual Meeting (SITC 2023) Abstracts. BMJ Publishing Group Ltd, 2023. http://dx.doi.org/10.1136/jitc-2023-sitc2023.0295.
Pełny tekst źródłaMatsuda, Tatsuo, Taigo Kato, Yuji Ikeda, Matthias Leisegang, Sachiko Yoshimura, Tetsuro Hikichi, Makiko Harada i in. "Abstract 625: Eradication of cancer cells by T-cell receptor-engineered T cells targeting neoantigens/oncoantigens". W Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-625.
Pełny tekst źródłaGreenberg, Philip D., Sebastian Ochsenreither, Tom Schmitt, David Aggen, David Kranz, Matthias Wolfl, Jurgen Kuball i in. "Abstract IA1: T cells vs. tumor cells: Arming/deploying T cells for a successful battle." W Abstracts: AACR Special Conference on Tumor Immunology: Multidisciplinary Science Driving Basic and Clinical Advances; December 2-5, 2012; Miami, FL. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.tumimm2012-ia1.
Pełny tekst źródłaKristensen, Nikolaj Pagh, Christina Heeke, Siri A. Tvingsholm, Anne-Mette Bjerregaard, Arianna Draghi, Amalie Kai Bentzen, Rikke Andersen, Marco Donia, Inge Marie Svane i Sine Reker Hadrup. "Abstract A14: Neoepitope-specific CD8+ T cells in adoptive T-cell transfer". W Abstracts: AACR Special Conference on Tumor Immunology and Immunotherapy; November 17-20, 2019; Boston, MA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/2326-6074.tumimm19-a14.
Pełny tekst źródłaJing, Ran, Mohamad Najia, Eleanor Meader, Luca Hensch, Edroaldo Lummertz da Rocha, R. Grant Rowe, Thorsten Schlaeger, Marcela Maus, Trista North i George Daley. "950 Epigenetic reprogramming of iPSC-derived T cells for CAR T cell therapy". W SITC 38th Annual Meeting (SITC 2023) Abstracts. BMJ Publishing Group Ltd, 2023. http://dx.doi.org/10.1136/jitc-2023-sitc2023.0950.
Pełny tekst źródłaHwang, Sunhee, Young H. Kim, Yeeun Bak i Byoung S. Kwon. "442-L Development of Panck T cells, MR1-restricted pan-cancer-killing CD8+T cells, as an adoptive T cell therapeutics". W SITC 38th Annual Meeting (SITC 2023) Abstracts Supplement 2. BMJ Publishing Group Ltd, 2023. http://dx.doi.org/10.1136/jitc-2023-sitc2023.0442-l.
Pełny tekst źródłaQian, Feng, Jianqun Liao, Anthony J. Miliotto, Katherine A. Collins i Kunle Odunsi. "Abstract A35: Ovarian cancer stem cells subvert tumor-specific T cells by disrupting T cells’ metabolic fitness". W Abstracts: AACR Special Conference: Addressing Critical Questions in Ovarian Cancer Research and Treatment; October 1-4, 2017; Pittsburgh, PA. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1557-3265.ovca17-a35.
Pełny tekst źródłaRaporty organizacyjne na temat "T cells"
Chen, Xiuxu, i Jenny E. Gumperz. Human CD1d-Restricted Natural Killer T (NKT) Cell Cytotoxicity Against Myeloid Cells. Fort Belvoir, VA: Defense Technical Information Center, kwiecień 2006. http://dx.doi.org/10.21236/ada462826.
Pełny tekst źródłaWong, Jr, i K. K. Regulatory T Cells and Host Anti-CML Responses. Fort Belvoir, VA: Defense Technical Information Center, czerwiec 2008. http://dx.doi.org/10.21236/ada487614.
Pełny tekst źródłaWong, Jr, i K. K. Regulatory T Cells and Host Anti-CML Responses. Fort Belvoir, VA: Defense Technical Information Center, czerwiec 2009. http://dx.doi.org/10.21236/ada510759.
Pełny tekst źródłaKnutson, Keith L. CD8 T Cells and Immunoediting of Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, sierpień 2008. http://dx.doi.org/10.21236/ada624685.
Pełny tekst źródłaJunghans, Richard P. Designer T-Cells for Breast Cancer Therapy: Phase I Studies. Fort Belvoir, VA: Defense Technical Information Center, lipiec 1999. http://dx.doi.org/10.21236/ada394380.
Pełny tekst źródłaJunghans, Richard P. Designer T Cells for Breast Cancer Therapy: Phase I Studies. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2001. http://dx.doi.org/10.21236/ada398295.
Pełny tekst źródłaJunghans, Richard P. Designer T Cells for Breast Cancer Therapy: Phase I Studies. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2002. http://dx.doi.org/10.21236/ada408881.
Pełny tekst źródłaJunghans, Richard. Designer T Cells for Breast Cancer Therapy: Phase I Studies. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2000. http://dx.doi.org/10.21236/ada383028.
Pełny tekst źródłaCoukos, George. Targeting Breast Cancer with T Cells Redirected to the Vasculature. Addendum. Fort Belvoir, VA: Defense Technical Information Center, październik 2012. http://dx.doi.org/10.21236/ada570217.
Pełny tekst źródłaMarshall, Renee M. Regulation of T-Type Cyclin/CDK9 Complexes in Breast Cancer Cells. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2005. http://dx.doi.org/10.21236/ada460789.
Pełny tekst źródła